CY1368A - Sustained release theophylline tablet having reduced bulk - Google Patents

Sustained release theophylline tablet having reduced bulk Download PDF

Info

Publication number
CY1368A
CY1368A CY136881A CY136881A CY1368A CY 1368 A CY1368 A CY 1368A CY 136881 A CY136881 A CY 136881A CY 136881 A CY136881 A CY 136881A CY 1368 A CY1368 A CY 1368A
Authority
CY
Cyprus
Prior art keywords
theophylline
tablet
pharmaceutical tablet
tablet according
weight
Prior art date
Application number
CY136881A
Other languages
English (en)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CY1368A publication Critical patent/CY1368A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY136881A 1980-05-06 1981-05-06 Sustained release theophylline tablet having reduced bulk CY1368A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14742980A 1980-05-06 1980-05-06
US24978781A 1981-04-01 1981-04-01

Publications (1)

Publication Number Publication Date
CY1368A true CY1368A (en) 1987-08-07

Family

ID=26844921

Family Applications (1)

Application Number Title Priority Date Filing Date
CY136881A CY1368A (en) 1980-05-06 1981-05-06 Sustained release theophylline tablet having reduced bulk

Country Status (17)

Country Link
AT (1) AT380789B (enrdf_load_stackoverflow)
AU (1) AU549299B2 (enrdf_load_stackoverflow)
CA (1) CA1165241A (enrdf_load_stackoverflow)
CY (1) CY1368A (enrdf_load_stackoverflow)
DE (1) DE3117756A1 (enrdf_load_stackoverflow)
DK (1) DK155976C (enrdf_load_stackoverflow)
FI (1) FI811356A7 (enrdf_load_stackoverflow)
FR (1) FR2484253A1 (enrdf_load_stackoverflow)
GB (1) GB2078518B (enrdf_load_stackoverflow)
HK (1) HK4288A (enrdf_load_stackoverflow)
IE (1) IE51157B1 (enrdf_load_stackoverflow)
IT (1) IT1209867B (enrdf_load_stackoverflow)
KE (1) KE3722A (enrdf_load_stackoverflow)
LU (1) LU83342A1 (enrdf_load_stackoverflow)
NL (1) NL8102168A (enrdf_load_stackoverflow)
SE (1) SE452550B (enrdf_load_stackoverflow)
SG (1) SG30987G (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
FR2595945B1 (fr) * 1986-03-19 1990-01-19 Doms Laboratoires Comprime-retard de theophylline a base de p.v.c., et son procede de preparation
USD557612S1 (en) * 2006-04-10 2007-12-18 Parfums Christian Dior Flask for a cosmetic product

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636568A (enrdf_load_stackoverflow) * 1961-01-31
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion

Also Published As

Publication number Publication date
SE8102814L (sv) 1981-11-07
DK200181A (da) 1981-11-07
FI811356L (fi) 1981-11-07
NL8102168A (nl) 1981-12-01
SE452550B (sv) 1987-12-07
DE3117756A1 (de) 1982-04-29
DK155976B (da) 1989-06-12
KE3722A (en) 1987-04-30
LU83342A1 (fr) 1982-01-20
DK155976C (da) 1989-10-30
SG30987G (en) 1987-07-17
IE51157B1 (en) 1986-10-15
GB2078518A (en) 1982-01-13
FR2484253B1 (enrdf_load_stackoverflow) 1983-06-03
CA1165241A (en) 1984-04-10
HK4288A (en) 1988-01-29
GB2078518B (en) 1984-04-11
FR2484253A1 (fr) 1981-12-18
AU7020581A (en) 1981-11-12
FI811356A7 (fi) 1981-11-07
IT8148406A0 (it) 1981-05-06
IE810989L (en) 1981-11-06
AT380789B (de) 1986-07-10
AU549299B2 (en) 1986-01-23
ATA202081A (de) 1985-12-15
IT1209867B (it) 1989-08-30
DE3117756C2 (enrdf_load_stackoverflow) 1992-11-26

Similar Documents

Publication Publication Date Title
US4465660A (en) Sustained release tablet containing at least 95 percent theophylline
US4837032A (en) Theophylline sustained release tablet
US4547358A (en) Sustained release tablet containing at least 95 percent theophylline
EP1242091B1 (en) Use of pharmaceutical compositions comprising oxcarbazepine in the fasted state
EP0261213B1 (en) Formulation for preparing sustained release drugs for oral administration
AU764742B2 (en) Dispersible compositions containing L-DOPA ethyl ester
US4692337A (en) Sustained release pharmaceutical tablet of theophylline and production process thereof
US20110177168A1 (en) Composition
NZ238131A (en) Chewable medicament tablets formed from compressed coated granules; coating is a polymer blend masking taste and providing sustained release
JPH0753365A (ja) γ−ヒドロキシ酪酸塩による制御放出能をもつ薬化学組成物
US5151273A (en) Delayed-release pharmaceutical preparation
PT85128B (pt) Processo para a preparacao de composicoes farmaceuticas contendo, como ingrediente activo, 4-(1-metil-4-piperidilideno)-4h-benzo-{4,5}ciclohepta{1,2-b}tiofeno--10(9h)-ona
CY1368A (en) Sustained release theophylline tablet having reduced bulk
Jonkman Food interactions with once-a-day theophylline preparations: a review
US5077294A (en) Products containing verapamil or gallopamil and prazosin
JPH0136444B2 (enrdf_load_stackoverflow)
Tambe Formulation and Evaluation of Paracetamol Effervescent Tablet
WO2007143290A2 (en) Delayed-release compositions of extended release forms of venlafaxine
RU2742745C1 (ru) Лекарственная форма в виде капсулы, содержащая таблетки с диметилфурмаратом
CN115400091A (zh) 一种酒石酸丙酚替诺福韦片药物组合物及其制备方法
Alagarsamy et al. FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLETS OF GRANISETRON HYDROCHLORIDE USING PLANTAGO OVATE AS NATURAL SUPERDISINTEGRANTS
CH646605A5 (en) Theophylline tablet with delayed release of active substance